Manejo del paciente con Hipertiroidismo en consulta externa de la Unidad Técnica de Endocrinología del Hospital Carlos Andrade Marín

Garay García, Karla Johana; Cadena Alvear, Carlos Humberto; Gordón Herrera, Diana Elizabeth; Rivadeneira Cevallos, María Gabriela; Vitar Checa, Gladys Ximena; Reyes Matute, Cristian Marcelo.
Cambios rev. méd ; 22 (2), 2023;22(2): 927, 16 octubre 2023. ilus, tabs
Artigo em Espanhol | LILACS | ID: biblio-1516527

Similares

  1. Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves' ophthalmopathy in comparison to hyperthyroid patients without Graves' ophthalmopathy.
  2. [What's new in endocrinology].
  3. Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
  4. Recent advances in the management of thyroid associated orbitopathy: A promising roadmap.
  5. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
  6. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
  7. The risk factors for Graves' ophthalmopathy.
  8. Current Therapeutic Approaches for Graves' Orbitopathy - are Targeted Therapies the Future?
  9. Management of Graves ophthalmopathy - 2022 update.
  10. Hypo vs. hyperthyroid eye disease: is there any difference?